Peter E. Boyd - Net Worth and Insider Trading
Peter E. Boyd Net Worth
The estimated net worth of Peter E. Boyd is at least $301,827 dollars as of 2024-11-12. Peter E. Boyd is the SVP-Bus. Process & Info. Tech. of Aquestive Therapeutics Inc and owns about 59,532 shares of Aquestive Therapeutics Inc (AQST) stock worth over $301,827. Details can be seen in Peter E. Boyd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter E. Boyd has not made any transactions after 2022-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter E. Boyd
Peter E. Boyd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter E. Boyd owns 1 companies in total, including Aquestive Therapeutics Inc (AQST) .
Click here to see the complete history of Peter E. Boyd’s form 4 insider trades.
Insider Ownership Summary of Peter E. Boyd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AQST | Aquestive Therapeutics Inc | 2022-06-14 | SVP-Operations/Value Delivery |
Peter E. Boyd Latest Holdings Summary
Peter E. Boyd currently owns a total of 1 stock. Peter E. Boyd owns 59,532 shares of Aquestive Therapeutics Inc (AQST) as of June 14, 2022, with a value of $301,827.
Latest Holdings of Peter E. Boyd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics Inc | 2022-06-14 | 59,532 | 5.07 | 301,827 |
Holding Weightings of Peter E. Boyd
Peter E. Boyd Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter E. Boyd has made a total of 3 transactions in Aquestive Therapeutics Inc (AQST) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Aquestive Therapeutics Inc is the acquisition of 5,000 shares on June 14, 2022, which cost Peter E. Boyd around $4,050.
Insider Trading History of Peter E. Boyd
- 1
Peter E. Boyd Trading Performance
GuruFocus tracks the stock performance after each of Peter E. Boyd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter E. Boyd is 73.05%. GuruFocus also compares Peter E. Boyd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter E. Boyd within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter E. Boyd's insider trading performs compared to the benchmark.
Performance of Peter E. Boyd
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.96 | | | | | |
| Relative Return to S&P 500(%) | 13.13 | | | | | |
Peter E. Boyd Ownership Network
Ownership Network List of Peter E. Boyd
Ownership Network Relation of Peter E. Boyd
Peter E. Boyd Owned Company Details
What does Aquestive Therapeutics Inc do?
Who are the key executives at Aquestive Therapeutics Inc?
Peter E. Boyd is the SVP-Operations/Value Delivery of Aquestive Therapeutics Inc. Other key executives at Aquestive Therapeutics Inc include director & Chief Innovation/Tech Officer Alexander Mark Schobel , Chief Medical Officer Carl N Kraus , and SVP & Research & Development Stephen Wargacki .
Aquestive Therapeutics Inc (AQST) Insider Trades Summary
Over the past 18 months, Peter E. Boyd made no insider transaction in Aquestive Therapeutics Inc (AQST). Other recent insider transactions involving Aquestive Therapeutics Inc (AQST) include a net sale of 75,000 shares made by Alexander Mark Schobel ,
In summary, during the past 3 months, insiders sold 0 shares of Aquestive Therapeutics Inc (AQST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 75,000 shares of Aquestive Therapeutics Inc (AQST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 75,000 shares.
Aquestive Therapeutics Inc (AQST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aquestive Therapeutics Inc Insider Transactions
Peter E. Boyd Mailing Address
Above is the net worth, insider trading, and ownership report for Peter E. Boyd. You might contact Peter E. Boyd via mailing address: 30 Technology Drive, Warren Nj 07059.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
